| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4029921
[patent_doc_number] => 05942232
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-24
[patent_title] => 'Composition with plant additives and treatment method for reducing stress levels in fish'
[patent_app_type] => 1
[patent_app_number] => 8/739407
[patent_app_country] => US
[patent_app_date] => 1996-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3525
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/942/05942232.pdf
[firstpage_image] =>[orig_patent_app_number] => 739407
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/739407 | Composition with plant additives and treatment method for reducing stress levels in fish | Oct 28, 1996 | Issued |
Array
(
[id] => 4086219
[patent_doc_number] => 06025338
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Nucleic acid vaccines against rickettsial diseases and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/733230
[patent_app_country] => US
[patent_app_date] => 1996-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 1
[patent_no_of_words] => 6420
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025338.pdf
[firstpage_image] =>[orig_patent_app_number] => 733230
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/733230 | Nucleic acid vaccines against rickettsial diseases and methods of use | Oct 16, 1996 | Issued |
| 08/727084 | NUCLEIC ACID ENCODING SPINOCEREBELLAR ATAXIA-2 AND PRODUCTS RELATED THERETO | Oct 7, 1996 | Abandoned |
| 90/004410 | RECOMINANT DNA TRANSFER VECTORS | Sep 29, 1996 | Issued |
Array
(
[id] => 3738664
[patent_doc_number] => 05753506
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals'
[patent_app_type] => 1
[patent_app_number] => 8/719450
[patent_app_country] => US
[patent_app_date] => 1996-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 46
[patent_no_of_words] => 14234
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753506.pdf
[firstpage_image] =>[orig_patent_app_number] => 719450
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/719450 | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals | Sep 24, 1996 | Issued |
Array
(
[id] => 3688699
[patent_doc_number] => 05691313
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-25
[patent_title] => 'Methods of treating impotency with ciliary neurotrophic factor'
[patent_app_type] => 1
[patent_app_number] => 8/704479
[patent_app_country] => US
[patent_app_date] => 1996-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3365
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/691/05691313.pdf
[firstpage_image] =>[orig_patent_app_number] => 704479
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/704479 | Methods of treating impotency with ciliary neurotrophic factor | Aug 25, 1996 | Issued |
| 90/004374 | RECOMBINANT DNA TRANSFER VECTORS | Aug 14, 1996 | Issued |
Array
(
[id] => 4086837
[patent_doc_number] => 06017878
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Nerve growth factor structural analogs and their uses'
[patent_app_type] => 1
[patent_app_number] => 8/696854
[patent_app_country] => US
[patent_app_date] => 1996-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 20
[patent_no_of_words] => 9672
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/017/06017878.pdf
[firstpage_image] =>[orig_patent_app_number] => 696854
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/696854 | Nerve growth factor structural analogs and their uses | Aug 6, 1996 | Issued |
Array
(
[id] => 3923935
[patent_doc_number] => 05952194
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-14
[patent_title] => 'Flea nucleic acid sequences and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/690849
[patent_app_country] => US
[patent_app_date] => 1996-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17796
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/952/05952194.pdf
[firstpage_image] =>[orig_patent_app_number] => 690849
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/690849 | Flea nucleic acid sequences and uses thereof | Jul 31, 1996 | Issued |
Array
(
[id] => 4168023
[patent_doc_number] => 06140117
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Ninjurin'
[patent_app_type] => 1
[patent_app_number] => 8/672850
[patent_app_country] => US
[patent_app_date] => 1996-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 18947
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/140/06140117.pdf
[firstpage_image] =>[orig_patent_app_number] => 672850
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/672850 | Ninjurin | Jul 23, 1996 | Issued |
Array
(
[id] => 3645245
[patent_doc_number] => 05655492
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-12
[patent_title] => 'Labyrinth manifold'
[patent_app_type] => 1
[patent_app_number] => 8/672830
[patent_app_country] => US
[patent_app_date] => 1996-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 2703
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/655/05655492.pdf
[firstpage_image] =>[orig_patent_app_number] => 672830
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/672830 | Labyrinth manifold | Jun 27, 1996 | Issued |
Array
(
[id] => 3935634
[patent_doc_number] => 05939534
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-17
[patent_title] => 'Factors mutated in the D1 cap region'
[patent_app_type] => 1
[patent_app_number] => 8/669284
[patent_app_country] => US
[patent_app_date] => 1996-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 26
[patent_no_of_words] => 15586
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/939/05939534.pdf
[firstpage_image] =>[orig_patent_app_number] => 669284
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/669284 | Factors mutated in the D1 cap region | Jun 27, 1996 | Issued |
| 08/672351 | BRAIN GLYCOGEN PHOSPHORYLASE CANCER ANTIGEN | Jun 24, 1996 | Abandoned |
Array
(
[id] => 1477589
[patent_doc_number] => 06451554
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Ion channel'
[patent_app_type] => B1
[patent_app_number] => 08/669656
[patent_app_country] => US
[patent_app_date] => 1996-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 42141
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451554.pdf
[firstpage_image] =>[orig_patent_app_number] => 08669656
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/669656 | Ion channel | Jun 23, 1996 | Issued |
| 08/660603 | LIVER RETENTION CLEARING AGENTS | Jun 5, 1996 | Abandoned |
| 08/649740 | HUMAN PROTEIN DISULFIDE ISOMERASE | May 14, 1996 | Abandoned |
Array
(
[id] => 4380152
[patent_doc_number] => 06277635
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Use of interleukin-10 to produce a population of suppressor cells'
[patent_app_type] => 1
[patent_app_number] => 8/643810
[patent_app_country] => US
[patent_app_date] => 1996-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 28
[patent_no_of_words] => 26023
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277635.pdf
[firstpage_image] =>[orig_patent_app_number] => 643810
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/643810 | Use of interleukin-10 to produce a population of suppressor cells | May 5, 1996 | Issued |
Array
(
[id] => 4180750
[patent_doc_number] => 06150125
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Flea protease proteins and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/639075
[patent_app_country] => US
[patent_app_date] => 1996-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 88374
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 707
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150125.pdf
[firstpage_image] =>[orig_patent_app_number] => 639075
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/639075 | Flea protease proteins and uses thereof | Apr 23, 1996 | Issued |
Array
(
[id] => 3824125
[patent_doc_number] => 05731206
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Method and reagent system for isolation, identification and/or analysis of leukocytes from whole blood samples'
[patent_app_type] => 1
[patent_app_number] => 8/630868
[patent_app_country] => US
[patent_app_date] => 1996-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8676
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/731/05731206.pdf
[firstpage_image] =>[orig_patent_app_number] => 630868
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/630868 | Method and reagent system for isolation, identification and/or analysis of leukocytes from whole blood samples | Mar 28, 1996 | Issued |
Array
(
[id] => 3852981
[patent_doc_number] => 05767242
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Isolated dimeric fibroblast activation protein alpha, and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/619280
[patent_app_country] => US
[patent_app_date] => 1996-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6627
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767242.pdf
[firstpage_image] =>[orig_patent_app_number] => 619280
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/619280 | Isolated dimeric fibroblast activation protein alpha, and uses thereof | Mar 17, 1996 | Issued |